Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Int J Cancer. 2012 Jul 2;131(9):1969–1982. doi: 10.1002/ijc.27650

Figure 2.

Figure 2

Meta-analysis of the main outcomes from randomised trials comparing HPV- and cytology-based cervical cancer screening. Relative detection rate of CIN3+ (left panel) and cervical cancer (right panel), observed in the second screening round among women who were HPV-negative versus cytology-negative at enrolment. * restricted to women 35 years or older.